Before submission of the manuscript to the journal, kindly check the below-mentioned guidelines
All persons who qualify for authorship should be listed as authors. However, the corresponding author must ensure that each author listed has substantially contributed or participated sufficiently in the work and is responsible for that particular portion of the manuscript. However, people who do not qualify for authorship should be listed in acknowledgments.
First name and last name
Complete affiliation, along with the country
E-mail address (mandatory for the corresponding author)
Submission FormatSubmissions to Pubtexto journals should include the following:
Figures and Tables
Authors are encouraged to submit all the components as 'zip file' while submitting on our online system or via email as an attachment.
Cover Letter should
briefly summarize or provide an outline of your manuscript, and why it is a worthy contribution to the concerned journal;
specify the Pubtexto journal that your manuscript best pertains to;
indicate, if applicable, that it is submitted as a part of Special Issue;
specify the manuscript type (original research, review, etc.)
detail any previous interaction(s) with Pubtexto Publications (previously submitted)
specify all authors' information, including affiliation
include acknowledgments and funding information (if applicable) and any competing interests
The word count for original research is 3500–4000 words and up to 5500 words for studies involving meta-analysis. Authors are encouraged to employ a standard and concise writing style. If you are not a native English speaker, we encourage you to utilize our language editing services-or ask a native English speaking colleague for assistance.
The title should not exceed 200 characters and set in title case. The title should be concise, specific, and easily comprehensible to readers.
The abstract should not exceed 300 words and may or may not be unstructured (without sub-heading such as objective, methodology, results, discussion, etc.). It should provide a clear description of the objective(s) of the study, demonstrate the methodology used, and summarize the study's prime conclusion(s). In the end, a statement regarding the study's significance to a potentially wider audience should be included. Keywords Authors can provide 4-6 keywords. The first letter of each keyword should be upper case, and keywords should be separated by a semicolon (;)
Main Text: Introduction The introduction should set the tone of the paper by providing a clear statement of the study, the relevant literature on the study subject and the proposed approach or solution. The introduction should be general enough to attract a reader's attention from a broad range of scientific disciplines.
Materials and methods This section should provide a complete overview of the design of the study. Detailed descriptions of materials or participants, comparisons, interventions, and types of analysis should be mentioned. However, only new procedures should be described in detail; previously published procedures should be cited and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address.
Results and Discussion The results section should provide complete details of the experiment that are required to support the conclusion of the study. The results should be written in the past tense when describing findings in the authors' experiments. Previously published findings should be written in the present tense. Results and discussion may be combined or in a separate section. Speculation and detailed interpretation of data should not be included in the results but should be put into the discussion section.
Conclusion This section should provide to adhere to support the study conclusions. This section included briefly detailed conclusive parameters of the whole study.
Acknowledgments This should include all the people who have contributed toward the work in one way or the other. However, authors are required to ensure that people acknowledged should agree to be so named.
Funding Information List all the sources of funding, including relevant research grant numbers, as applicable. Also, authors are encouraged to list all the contributing authors associated with specific funding, if applicable.
Optional information While we are not obligated to use these or recommend to the concerned Editor(s), we do encourage authors to provide names and contact information of 2-4 external reviewers and, if applicable, 1-2 opposed reviewers.
References Published work along with any citable items should be cited in the reference list. While we follow very stringent reference formats, authors need not to spend time formatting their reference. They can submit the manuscripts formatted in any reference style (style will be formatted once the manuscript is accepted for publication), but it is preferable that they adhere to the journal format. Reference format: Pubtexto uses the following style. Items are listed numerically in the order they are cited in the text. Example journal article (2-6 authors): Salwachter AR, Freischlag JA, Sawyer RG, Sanfey HA, Fukushima H, Cureoglu. The training needs and priorities of male and female surgeons and their trainees. J Am Coll Surg. 2005; 201: 199-205. Example journal article (more than 6 authors): Fukushima H, Cureoglu S, Schachern P, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg. 2005; 133: 100-6. Example book: Modlin J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the United States. San Francisco, CA: Pediatric Academic Societies; 2004. Example book chapter: Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585-606. online article: Wolf W. State's mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:1B Example article from any database: Calhoun D, Trimarco T, Meek R, Locasto D. Distinguishing diabetes: Differentiate between type 1 & type 2 DM. JEMS [serial online]. November 2011; 36(11):32-48. Available from: CINAHL Plus with Full Text, Ipswich, MA. Accessed February 2, 2012. In-text citation: For referencing an article, a number is used. This is different from in-text citations in AMA—author's last name is not used. The order of numbering will be contingent on the order in which you use that reference within your paper. For example, the first article referenced will be given number one in superscript (1) followed by the second and third articles as 2,3. In the references section, the articles should appear numerically in the order they are cited within the text.
Figures and Tables Figures and tables should be included in the main text (manuscript) to aid in the review process. However, for larger files (size exceeding 10 Mb) must always be submitted separately (should be properly mentioned in the main text, wherever applicable).
Figure captions and legends Figure files should be included in the main document, and not as supplemental materials. Figure caption should be preceded by the figure, while figure legends should immediately follow the figure. Figure captions should be concise (not to exceed 18 words) and set in bold type. All figures should be numbered in sequence, using Arabic numerals, for example, Figure 1, Figure 2, etc.
Table captions and legends Tables should be cited in ascending numeric order. Each table should be preceded by a table caption (brief and specific; not to exceed 18 words), and immediately followed by table legends, if applicable, used to explain abbreviations and other supporting information about the data. Larger tables, however, can be submitted as supplemental materials.
Review Comments and Revision Submission Instructions While submitting a revised manuscript, the authors should include the following: Revised manuscript (clean copy): Prepare a clean copy of your revised manuscript that does not show track changes. Rename this file as "Main Document". Revised manuscript (marked-up copy): Include a copy of your manuscript file showing the changes you have made (track changes). Rename this file as "Manuscript with Track Changes". Response to reviewers: Address the specific points made by each Reviewer and/or Editor. Include your responses to all the reviewers' and editor's comments and list the changes you have made to the manuscript. Rename this file as "Response to Reviewers".
Supplementary Information Information integral to the comprehensive understanding of the manuscript, but is either too large to be included in the main document or due to any other reason, should be submitted as support materials, such as 3-D visualizations, interactive graphics, large tables and/or figures, and so on. However, authors should note that normal figures and tables should not be included under supplemental materials.
Ethical Guidelines For manuscripts reporting medical studies that involve human or animal subjects, the ethics committee that approved the study must be identified in the manuscript. For studies involving human subjects, all work must conform to the recognized standards as per the "Declaration of Helsinki". In case of any experiments involving animals, authors must provide a declaration that all measures were taken to avoid animal suffering at each stage and also must furnish a detailed description of the procedures used.
Patient Consent In manuscripts reporting patient cases, patient anonymity must be preserved. Case reports submitted to Pubtexto Publications should conform to the International Committee of Medical Journal Editors' (ICMJE) recommendations. Patient privacy should be taken care of, and personally, identifiable information should not be revealed without informed consent. If informed consent has been obtained, the details must be mentioned in the manuscript. For live patients, signed consent is mandatory if the authors wish to reveal the patient's identity. In the case of deceased patients, consent must be taken from the patient's next of kin. If a patient's consent was not obtained, the patient's details should be anonymized as much as possible. The patient's photographs need to be cropped sufficiently to prevent the revelation of identity. The authors are not required to submit a copy of the patient's consent while submitting their manuscript for consideration in Pubtexto Publications. However, they should confirm in the Cover Letter that the patient's consent has been obtained. In certain instances, the Editorial Office might request the authors to provide a copy of the same.
Benefits of Open Access include greater visibility, accelerated citation, immediate access to the full-text versions, higher impact and authors retain the copyright to their work. All open access articles are published under the terms of the Creative Commons Attribution (CC-BY) license. It also allows immediate deposit of the final published version in other repositories without restriction on re-use.
Article Processing Charges
Publishing under Open Access mode involves a publication fee of 2919 GBP. If authors wish to retract their paper after rigorous review and revisions, he/she will be labeled to pay 85% of the total expenses on their article as a fee for processing. Since, the review process requires the input of Editors, Reviewers, Associate Managing Editors, Editorial Assistants, Content Writers, Editorial Managing systems & other online tracking systems to ensure that the published article is of good quality and is in its best possible form.
For Fast track services: The charges are different apart from the charges mentioned above
For charges, you can contact us at the below email address
Authors opted for subscription mode must sign a copyright transfer agreement prior to publication of their article. Publisher reserves the copyright and any extensions or renewals of that term thereof throughout the world, including but not limited to publish, disseminate, transmit, store, translate, distribute, sell, republish and use the contribution and material contained therein in print and electronic form of the journal and in other derivative works, in all languages and any form of media of expression available now or in the future and to license or permit others to do so.